US approves first Pill with Digital Tracking Device
November 16th, 2017
The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them. The drug Abilify MyCite, developed by Otsuka Pharmaceutical Co. Ltd, was first approved by the FDA in 2002 to treat schizophrenia. The ingestible sensor, made by Proteus Digital health, was approved for marketing in 2012.